Results 41 to 50 of about 155,757 (387)

Patient‐Reported Outcomes with Selpercatinib Treatment Among Patients with RET‐Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO‐001 Trial

open access: yesThe Oncologist, EarlyView., 2021
Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth   +10 more
wiley   +1 more source

Aneurysmal bone cyst at C2: imaging evaluation after intralesional injection of calcitonin and methylprednisolone Cisto ósseo aneurismático em C2: avaliação por imagem após injeção intralesional de calcitonina e metilprednisolona

open access: yesArquivos de Neuro-Psiquiatria, 2008
Objective: To demonstrate imaging findings during the follow-up of patients with aneurysmal bone cyst (ABC) of C2 treated with intralesional injection of calcitonin and methylprednisolone. METHOD: Three patients with ABC of C2 were treated percutaneously
Elise T. Tonomura   +4 more
doaj   +1 more source

Oral calcitonin

open access: yesInternational Journal of Women's Health, 2012
Calcitonin is a hormone secreted by the C-cells of the thyroid gland in response to elevations of the plasma calcium level. It reduces bone resorption by inhibiting mature active osteoclasts and increases renal calcium excretion. It is used in the management of postmenopausal osteoporosis, Paget's disease of bone, and malignancy-associated ...
Hamdy, Ronald C., Daley, Dane N.
openaire   +6 more sources

The neuropeptide transcriptome of a model echinoderm, the sea urchin Strongylocentrotus purpuratus [PDF]

open access: yes, 2012
The work reported here was supported by a grant from the University of London Central Research ...
Elphick, MR, Rowe, ML
core   +1 more source

Triptans and CGRP blockade - impact on the cranial vasculature [PDF]

open access: yes, 2017
The trigeminovascular system plays a key role in the pathophysiology of migraine. The activation of the trigeminovascular system causes release of various neurotransmitters and neuropeptides, including serotonin and calcitonin gene-related peptide ...
Alejandro Labastida-Ramírez   +9 more
core   +3 more sources

Calcitonin receptor-like receptor is expressed on gastrointestinal immune cells [PDF]

open access: yes, 2002
Background/Aims: Pharmacological and morphological studies suggest that the gut mucosal immune system and local neuropeptide-containing neurones interact.
Göke, B.   +5 more
core   +1 more source

The effects of calcitonin on quality of life in hypothyroid patients – A pilot study

open access: yesEndocrine and Metabolic Science, 2023
Introduction: Hypothyroidism is a very common endocrine disorder routinely treated with levothyroxine replacement therapy. Despite treatment to biochemical euthyroidism, some individuals continue to have hypothyroidism-related symptoms.
Wedad Rahman   +6 more
doaj   +1 more source

Frequent mild head injury promotes trigeminal sensitivity concomitant with microglial proliferation, astrocytosis, and increased neuropeptide levels in the trigeminal pain system. [PDF]

open access: yes, 2017
BACKGROUND: Frequent mild head injuries or concussion along with the presence of headache may contribute to the persistence of concussion symptoms. METHODS: In this study, the acute effects of recovery between mild head injuries and the frequency of ...
Assari, Soroush   +4 more
core   +2 more sources

Distinct Patterns of Internalization of Different Calcitonin Gene-Related Peptide Receptors.

open access: yesACS Pharmacology & Translational Science, 2020
Calcitonin gene-related peptide (CGRP) is a neuropeptide that is involved in the transmission of pain. Drugs targeting CGRP or a CGRP receptor are efficacious in the treatment of migraine.
Joseph J Gingell   +9 more
semanticscholar   +1 more source

The Activity of Peptides of the Calcitonin Family in Bone.

open access: yesPhysiological Reviews, 2019
Calcitonin was discovered over 50 yr ago as a new hormone that rapidly lowers circulating calcium levels. This effect is caused by the inhibition of calcium efflux from bone, as calcitonin is a potent inhibitor of bone resorption.
D. Naot, D. Musson, J. Cornish
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy